Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$15.07 - $21.71 $6.55 Million - $9.43 Million
-434,527 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$12.72 - $16.16 $2.7 Million - $3.43 Million
-212,555 Reduced 32.85%
434,527 $6.57 Million
Q3 2020

Nov 16, 2020

SELL
$12.34 - $17.92 $3.14 Million - $4.56 Million
-254,632 Reduced 28.24%
647,082 $8.23 Million
Q2 2020

Aug 14, 2020

BUY
$12.39 - $17.33 $270,795 - $378,764
21,856 Added 2.48%
901,714 $15.4 Million
Q1 2020

May 14, 2020

BUY
$9.12 - $17.78 $1.18 Million - $2.3 Million
129,178 Added 17.21%
879,858 $11.6 Million
Q4 2019

Feb 14, 2020

BUY
$16.11 - $25.98 $632,623 - $1.02 Million
39,269 Added 5.52%
750,680 $12.1 Million
Q3 2019

Nov 14, 2019

SELL
$18.28 - $26.91 $4.42 Million - $6.5 Million
-241,595 Reduced 25.35%
711,411 $13 Million
Q2 2019

Aug 14, 2019

BUY
$17.68 - $21.57 $16.8 Million - $20.6 Million
953,006 New
953,006 $20.5 Million
Q1 2019

May 07, 2019

SELL
$14.41 - $19.64 $8.65 Million - $11.8 Million
-600,342 Closed
0 $0
Q4 2018

Feb 01, 2019

BUY
$12.45 - $23.47 $7.47 Million - $14.1 Million
600,342 New
600,342 $7.62 Million
Q3 2018

Nov 14, 2018

SELL
$17.57 - $23.95 $6.24 Million - $8.5 Million
-354,986 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$11.6 - $19.27 $203,000 - $337,225
17,500 Added 5.19%
354,986 $75,000
Q1 2018

May 15, 2018

BUY
$11.77 - $16.08 $2.48 Million - $3.39 Million
210,534 Added 165.84%
337,486 $3.99 Million
Q4 2017

Feb 14, 2018

BUY
$11.86 - $14.08 $1.51 Million - $1.79 Million
126,952
126,952 $1.63 Million

Others Institutions Holding CARA

About Cara Therapeutics, Inc.


  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $15M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track ETF Managers Group, LLC Portfolio

Follow ETF Managers Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.